Bond Laboratories, Inc.(Exact name of small business issuer as specified in its charter)
Nevada
(State or other jurisdiction of incorporation or organization)
20-3464383
(IRS Employer Identification No.)
11011 Q Street, Building A Suite 106, Omaha, Nebraska 68137
(Address of principal executive offices)
402-333-5260
(Registrant's Telephone number)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition.
On May 24, 2011, Bond Laboratories, Inc. (the "Company") issued a press release announcing continued strong revenue growth from operations for the month ended April 30, 2011. Total revenue increased 47% to approximately $903,180 from $614,474 for the month ended April 30, 2010, and year-to-date revenue improved 41% to $3.9 million for the four months ended April 30, 2011 as compared to $2.8 million over the same period last year. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1, and is incorporated herein by this reference. The information in this Current Report, including the Exhibit attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference to such filing.
Item 8.01 Other Events.
See item 2.02.
Item 9.01 Financial Statements and Exhibits.
See Exhibit Index.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 24, 2011
| By: |
/s/ Michael Abrams |
|
| Name: Michael Abrams |
| Title: Chief Financial Officer |
Exhibit Index
|
Exhibit No.
|
|
Description
|
|
EX-99.1
|
|
May 18, 2011 Press Release
|